Renee D. Gala is CEO & President at Jazz Pharmaceuticals plc (JAZZ). They have made 6 open-market trades across 3 companies since 2015, most recently 2026-10-06.
CIK 0001607737
2 open-market purchases totalling $277K since 2015, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL · 10b5-1 | 2026-10-06 | 2026-10-07 | $236.40 | $473K | — | — | — |
| JAZZ | SELL · 10b5-1 | 2026-09-08 | 2026-09-10 | $243.03 | $486K | -1.6% | -11.3% | — |
| JAZZ | SELL | 2023-05-18 | 2023-05-19 | $131.75 | $791K | -3.9% | -4.7% | +2.6% |
| JAZZ | SELL | 2022-12-21 | 2022-12-22 | $160.00 | $422K | -0.4% | -2.8% | -13.5% |
| TBPH | SELL | 2018-08-14 | 2018-08-16 | $26.78 | $2.3M | +4.2% | -2.1% | -10.6% |
| TBPH | SELL | 2018-05-18 | 2018-05-22 | $24.29 | $243K | +5.3% | +5.1% | +17.6% |
| CORT | BUY | 2018-03-06 | 2018-03-07 | $15.51 | $155K | +14.2% | -0.2% | +14.3% |
| TBPH | BUY | 2015-08-13 | 2015-08-17 | $12.18 | $122K | -16.4% | +1.4% | +1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.